ArticleBMC ophthalmology2026
Multi-omics-guided diagnosis and treatment of toxoplasma retinochoroiditis with co-infection: a case report.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundToxoplasma retinochoroiditis is challenging to diagnose and treat, especially in immunocompromised or co-infected individuals. This report describes a complex vision loss case in a syphilis and tuberculosis-history patient, demonstrating the utility of multi-omics in guiding diagnosis and treatment. A 50-year-old female with treated syphilis and tuberculosis had right eye floaters and visual disturbances, with panuveitis and retinal lesions on exam. Aqueous humor multi-omics confirmed Toxoplasma gondii (no syphilis or tuberculosis DNA), and she recovered with 8-week trimethoprim-sulfamethoxazole plus tapered prednisone (initiated 72h post-antimicrobial therapy).
conclusionThis case highlights the diagnostic challenges of ocular inflammation in patients with co-infections and demonstrates the value of multi-omics-guided intraocular fluid analysis for precise pathogen identification. This case supports a combined treatment strategy of anti-toxoplasmosis medication and cautious corticosteroid use, which-despite the risk of reactivating latent infections-can achieve excellent anatomical and visual outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.